Pappas Life Science Ventures VI, LP
Pappas Capital · adviser of record: Pappas Capital, LLC · 2022 vintage
Pappas Life Science Ventures VI, LP is a 2022 venture fund managed by Pappas Capital, with $250mm raised (Form D, amount sold). It reported $33.3mm in gross assets at year-end 2025, 0.13x its size, against a peak of $37mm in 2023.
- Latest value held
- $33.3mm year-end 2025
- Peak
- $37mm year-end 2023
- Fund size
- $250mm Form D, amount sold
- Held vs. size
- 0.13x peak 0.15x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $33.3mm | 0.13x | -10% over 2 yrs |
| 2023 | $37mm | 0.15x | – |
Other funds from Pappas Capital
- PV VI Ceo Fund, LP 2022
- Asia Innovation Ventures, LP 2021
- A.M. Pappas Life Science Ventures V, LP 2016
- PV V Ceo Fund, LP 2016
- Chiesi Ventures, LP 2014
- A. M. Pappas Life Science Ventures IV, LP 2011
- A. M. Pappas Life Science Ventures III, LP 2011
- A. M. Pappas Life Science Ventures II, LP 2011
- PV III Ceo Fund, LP 2011
- PV IV Ceo Fund, LP 2011
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-9250963335. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.